HNGE Stock Hinge Health, Inc.
STRONG BUY US · NYSEDigital musculoskeletal care growth and rising targets offer high-growth upside with execution risk.
Future value: $140.00 (+25.32%) · 6-12 months
Signal breakdown
- ▸KeyCorp raised its Overweight target to $140.
- ▸Above 50-day MA (+16.41%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (97.9% of range) — strength
- ▸~25% upside to price target
Is HNGE a buy right now?
Trend: HNGE is trading above the 50-day average (+16.41%), RSI 74 — overbought territory, with a 3-month return of +48.45%.
Valuation & quality: Hinge Health, Inc. trades on a trailing P/E of 36.9, forward P/E 36.5, price-to-book 26.02; fundamentals show net margin 15.1%, return on equity 30.4%, revenue growth 53.0% year on year.
Analyst consensus: 16 analysts have a mean 12-month price target of $114.31 (+2.3% vs the last close; range $90.00 – $140.00), consensus rating “buy”.
Our screen: STRONG BUY (score 6) — Digital musculoskeletal care growth and rising targets offer high-growth upside with execution risk.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -9.80% | +15.70% | +26.00% | +47.70% | -10.00% | +23.90% | +5.10% | +14.90% |
Fundamentals
Analyst price target
Technical signals
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
Sector: Healthcare · Industry: Health Information Services · United States · 1,437 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.